1Stein H,Warnke R,Chan W,et al.Diffuse large B-cell lymphoma,not otherwise specified.In S.Swerdlow(Ed.),WHO classification of tumours of haematopoietic and lymphoid tissues[M]France:IARC,Lyon,2008:233-237.
3Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer, 2000,89 : 1586-1592.
4Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med, 2002,346:235-242.
5Rossini F, Terruzzi E, Perego D, et al. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone. Cancer, 2004,100:350-355.
6Dixon DO, Neilan B, Jones SE, et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol, 1986,4:295-305.
7Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MINT) Group. Lancet Oncol, 2006, 7:379-391.
8Pfreundschuh M, Kloess M, Zeynalova S, et al. Six vs. Eight cycles of bi-weekly CHOP-14 with or without rituximab for elderly patients with diffuse large B-cell lymphoma (DLBCL) : resuhs of the completed RICOVER-60 trial of the German High-Grade NonHodgkin's Lymphoma Study Group (DSHNHL). Blood, 2006, 108 : 64a.
9Coiffier B. What treatment for elderly patients with aggressive lymphoma? Ann Oncol, 1994,5:873-875.
10Habermann T, Weller E, Morrison V, et al. Phase Ⅲ trial of rituximab-CHOP (R-CHOP) vs CHOP with a second randomization to maintenance rituximab ( MR ) or observation in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL). Blood, 2003,102:8a .
